menu search

Talon metals corp earns 'buy' rating from stifel in coverage initiation note

Stifel GMP analysts have initiated coverage of Talon Metals with a “Buy” rating and C$0.90 price target, calling the company's Tamarack nickel pro...

July 13, 2022, 11:19 am

Southern energy closes us$31m financing; secures premium to nymex natural gas pricing contract

Southern Energy Corp (TSX-V:SOU, AIM:SOUC, OTC:MAXMD) said it has completed its previously-announced US$31 million offering by issuing 46,371,927 new...

July 7, 2022, 11:05 am

Key takeaways from raymond james' initiation on doordash

Raymond James analyst Aaron Kessler initiated coverage on DoorDash, Inc (NYSE: DASH) with a Market Perform rating with no price target. Kessler sa...

June 6, 2022, 12:49 pm

D.a. davidson thinks rivian (rivn) stock can fall to $24

Shares of RIVN stock are in focus following an initiation of coverage from D.A. Davidson. The firm assi...

June 2, 2022, 11:48 am

Grindrod shipping: a high performer with little downside

Grindrod Shipping Holdings is a small-sized shipping company serving the global markets through a wide range of clients spanning a number of industrie...

May 17, 2022, 5:06 am

Academy sports: cash returning to shareholders with dividend initiation

Academy Sports and Outdoors posted fantastic Q42021 and FY2021 results, exceeding estimates and turning in its most profitable year in company history...

March 30, 2022, 6:23 pm

Red pine exploration announces publication of its inaugural 2021 esg report

Red Pine Exploration Inc (TSX-V:RPX, OTCQB:RDEXF) has announced the publication of its inaugural 2021 Environmental, Social and Governance (ESG) repor...

March 15, 2022, 7:54 am

Jaguar health shares replay link for march 14, 2022, investor webcast

Click here to access webcast replay Core 2022 development initiatives: Ongoing operation of Company's OnTarget Phase 3 clinical trial of crofelemer fo...

March 14, 2022, 1:15 pm

Mindmed advances phase 2a lsd microdose trial for adult adhd

Neuro-pharmaceutical and psychedelics company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) announced Friday the ...

December 17, 2021, 1:16 pm

Mindmed advances phase 2a lsd microdose trial for adult adhd

Neuro-pharmaceutical and psychedelics company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) announced Friday the ...

December 17, 2021, 1:16 pm

Mindmed advances phase 2a lsd microdose trial for adult adhd

Neuro-pharmaceutical and psychedelics company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) announced Friday the ...

December 17, 2021, 1:16 pm

Pharmaxis attracts a$0.53 price target in coverage initiation from mst access

Pharmaxis Ltd (ASX:PXS) has received a A$0.53 price target from MST Access in its just-released initiation...

November 7, 2021, 6:43 pm

Pharmaxis attracts a$0.53 price target in coverage initiation from mst access

Pharmaxis Ltd (ASX:PXS) has received a A$0.53 price target from MST Access in its just-released initiation...

November 7, 2021, 6:43 pm

Pharmaxis attracts a$0.53 price target in coverage initiation from mst access

Pharmaxis Ltd (ASX:PXS) has received a A$0.53 price target from MST Access in its just-released initiation...

November 7, 2021, 6:43 pm

Pasithea therapeutics corp. and evotec se enter into drug development agreement

-- Company contracts leading global drug development company to advance initial drug candidate -- Miami Beach, FL / October 11, 2021 -- Pasithea Thera...

October 11, 2021, 8:20 am

Pasithea therapeutics corp. and evotec se enter into drug development agreement

-- Company contracts leading global drug development company to advance initial drug candidate -- Miami Beach, FL / October 11, 2021 -- Pasithea Thera...

October 11, 2021, 8:20 am

Pasithea therapeutics corp. and evotec se enter into drug development agreement

-- Company contracts leading global drug development company to advance initial drug candidate -- Miami Beach, FL / October 11, 2021 -- Pasithea Thera...

October 11, 2021, 8:20 am

4d molecular to test its wet amd gene therapy in patients

The FDA has signed off 4D Molecular Therapeutics' (NASDAQ: FDMT) Investigational New Drug Application (IND) for 4D-150 for wet age-related macular ...

October 6, 2021, 8:27 am

4d molecular to test its wet amd gene therapy in patients

The FDA has signed off 4D Molecular Therapeutics' (NASDAQ: FDMT) Investigational New Drug Application (IND) for 4D-150 for wet age-related macular ...

October 6, 2021, 8:27 am

4d molecular to test its wet amd gene therapy in patients

The FDA has signed off 4D Molecular Therapeutics' (NASDAQ: FDMT) Investigational New Drug Application (IND) for 4D-150 for wet age-related macular ...

October 6, 2021, 8:27 am


Search within

Pages Search Results: